Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding
Open Access
- 22 May 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (10)
Abstract
Central glucose-dependent insulinotropic polypeptide (GIP) receptor (GIPR) signaling is critical in GIP-based therapeutics’ ability to lower body weight, but pathways leveraged by GIPR pharmacology in the brain remain incompletely understood. We explored the role of Gipr neurons in the hypothalamus and dorsal vagal complex (DVC) — brain regions critical to the control of energy balance. Hypothalamic Gipr expression was not necessary for the synergistic effect of GIPR/GLP-1R coagonism on body weight. While chemogenetic stimulation of both hypothalamic and DVC Gipr neurons suppressed food intake, activation of DVC Gipr neurons reduced ambulatory activity and induced conditioned taste avoidance, while there was no effect of a short-acting GIPR agonist (GIPRA). Within the DVC, Gipr neurons of the nucleus tractus solitarius (NTS), but not the area postrema (AP), projected to distal brain regions and were transcriptomically distinct. Peripherally dosed fluorescent GIPRAs revealed that access was restricted to circumventricular organs in the CNS. These data demonstrate that Gipr neurons in the hypothalamus, AP, and NTS differ in their connectivity, transcriptomic profile, peripheral accessibility, and appetite-controlling mechanisms. These results highlight the heterogeneity of the central GIPR signaling axis and suggest that studies into the effects of GIP pharmacology on feeding behavior should consider the interplay of multiple regulatory pathways.Keywords
Funding Information
- Eli Lilly and Company (N/A)
- EFSD, Novo Nordisk Foundation (NNF21SA0072744)
- Diabetes UK (NA)
- European Foundation for the Study of Diabetes (N/A)
- National Institutes of Health (DK123075,DK125353,DK046492,DK124276)
- Medical Research Scotland (MRC_MC_UU_12012/3)
- Wellcome Trust (220271/Z/20/Z)
- Medical Research Scotland (MR/W000881/1)
- HORIZON EUROPE Framework Programme (101042046)
- Medical Research Council, Diabetes UK, ERC Frontier Research Guarantee, Horizon 2020 Research and Innovation Programme (MR/N00275X/1,MR/S025618/1,17/0005681,EP/X026833/1,715884)
- Wellcome Trust (223279/Z/21/Z)
This publication has 54 references indexed in Scilit:
- Hindbrain Neurons as an Essential Hub in the Neuroanatomically Distributed Control of Energy BalanceCell Metabolism, 2012
- The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's DiseaseThe Journal of Neuroscience, 2011
- The arcuate nucleus as a circumventricular organ in the mouseNeuroscience Letters, 2011
- Hypothalamic nutrient sensing in the control of energy homeostasisBehavioural Brain Research, 2010
- Remote Control of Neuronal Activity in Transgenic Mice Expressing Evolved G Protein-Coupled ReceptorsNeuron, 2009
- Biology of Incretins: GLP-1 and GIPGastroenterology, 2007
- Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligandProceedings of the National Academy of Sciences, 2007
- C-fos expression in the rat brain following lithium chloride-induced illnessBrain Research, 2007
- Genome-wide atlas of gene expression in the adult mouse brainNature, 2006
- Human synapsin 1 gene promoter confers highly neuron-specific long-term transgene expression from an adenoviral vector in the adult rat brain depending on the transduced areaGene Therapy, 2003